MLD is a rare neurodegenerative disorder where every day counts. The earliest signs are often overlooked—mistaken as more common developmental or behavioral conditions. Through the Think Rare Program, we equip frontline healthcare professionals with the insights and tools to spot these early indicators, intervene sooner, and ultimately change the course of a child’s life.
Our international faculty comprises leading clinicians and researchers committed to transforming the MLD diagnostic journey.
The MLD Resource Centre is independently developed and managed by EiP regarding content, topics and speakers appointed. Unrestricted grants are sought to support EIP activities, and Orchard Therapeutics has provided an unrestricted grant to partially support EIP's work on the misdiagnosis of metabolic disorders.